جست‌وجوی استاد و پژوهشگر

Matthias Mannمشاهده پروفایل

استاد

• Mass Spectrometry
• Proteomics
• Systems Biology
• +۶ مورد دیگر

Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.

• Neural circuit mechanisms
• Adaptive learning
• State-dependent decision-making
• +۴ مورد دیگر

Dr. Sabine Krabbe is a Group Leader at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, Germany, where she leads research on neural circuit mechanisms underlying adaptive learning and state-dependent decision-making. Her work integrates neuroscience, molecular biology, and behavioral approaches to understand how internal states influence behavior and how these processes are disrupted in neurological disorders. Dr. Krabbe's research focuses on the interactions between midbrain circuits of the substantia nigra and ventral tegmental area with their output structures such as the striatum and amygdala. She investigates how these networks integrate internal states with environmental cues to produce appropriate behavioral responses. Her laboratory employs state-of-the-art techniques including deep-brain calcium imaging at single-cell resolution in mice, opto- and pharmacogenetic manipulations, anatomical tracings, and molecular approaches to characterize neural circuit elements in detail. Her recent publications reveal significant insights into amygdala interneuron plasticity during fear learning, brain-wide representational drift in memory consolidation, and the molecular mechanisms underlying Parkinson's disease progression. Her work demonstrates how activity patterns within specific neural circuits change in early stages of neurodegenerative diseases and how this dysfunction contributes to cognitive deficits and emotional disturbances. Dr. Krabbe is actively involved in the neuroscience community, organizing the BonnBrain Conference 2026 and sharing research through social media platforms. She has established herself as an emerging leader in the field of systems neuroscience with a particular focus on the neural basis of emotional states and decision-making processes.

Omer Bayraktarمشاهده پروفایل

پژوهشگر

• Neural Diversity
• Spatial Transcriptomics
• Glia Biology
• +۳ مورد دیگر

Omer Bayraktar is a Group Leader at the Wellcome Sanger Institute , leading research in the Cellular Genomics Programme. His work focuses on decoding human brain cellular diversity using spatial transcriptomics , imaging , and functional screening to study neural complexity in health and disease. Bayraktar's educational background includes a PhD from HHMI under Chris Doe, investigating neural diversity development in Drosophila , followed by postdoctoral work at University of California, San Francisco and University of Cambridge as a Life Sciences Research Foundation Fellow. He developed a spatial transcriptomic pipeline during his postdoc to analyze astrocyte heterogeneity in the cerebral cortex. His research explores neural cell type mapping , glial-neuronal interactions , and cellular pathways in neurodevelopmental disorders . Recent publications emphasize 3D tissue mapping , multi-omic integration , and computational tools like Cell2fate and WebAtlas. His work bridges neurogenetics and computational biology to advance understanding of human tissue ecosystems. Bayraktar's lab collaborates with the Human Cell Atlas initiative and develops technologies such as automated histology pipelines and highly-multiplexed smFISH for molecular cell typing. His team also investigates glia-based therapies and astrocyte functional heterogeneity in neurodevelopmental contexts. Key scientific contributions include: Discovering astrocyte layer patterns independent of neuronal laminae Developing cell2location for spatial cell mapping Characterizing Drosophila neural stem cell models with human relevance Notable awards include the Life Sciences Research Foundation Fellowship during his postdoctoral training. His current group includes a PhD student , Senior Data Scientists , and Bioinformaticians .

• Behavioral Ecology
• Evolutionary Biology
• Population Ecology
• +۱۱ مورد دیگر

Prof. Dr. Oliver Krüger is a behavioral ecologist and evolutionary biologist at Bielefeld University 's Faculty of Biology , where he leads the Department of Animal Behaviour since 2013. His research spans avian and marine mammal systems, focusing on life history strategies, parasite-host interactions, and environmental adaptation. Education: Biology studies at Bielefeld University (1994-1996) MSc in Oxford (1996-1997) PhD at Bielefeld University with Fritz Trillmich and Jan Lindström (1998-2000) Research Themes: Behavioral ecology, evolutionary biology, and population dynamics across tropical and temperate ecosystems. Key projects include NC³ (Niche Choice/Construction) and studies on Galápagos sea lions, common buzzards, and pinniped species. Scientific Leadership: Spokesperson, SFB TRR 212 "NC³" (2018-2025) Advisory Board member: German Ornithologists Union, IUCN SSC pinniped group, German Primate Centre Peer review roles: Humboldt Foundation, DFG, HFSP, NSF Awards: Leopoldina Prize (2001) Niko Tinbergen Award (2008) DFG Heisenberg Professorship (2010-2015)

Angelika Ramboldمشاهده پروفایل

استادیار

• Immunology
• Cell Biology
• Metabolism
• +۳ مورد دیگر

Dr. Angelika Rambold is a Group Leader at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany, heading the Laboratory for Metabolic Organelle Networks in Immunology within the Department of Developmental Immunology. Previously affiliated with the University of Münster's Center for Molecular Biology of Inflammation (ZMBE) and Institute of Medical Biochemistry until January 2025, she investigates how intracellular organelle networks regulate immune cell function during inflammation, infection, and metabolic stress. Her research centers on dynamic interactions between mitochondria, lysosomes, lipid droplets, and autophagosomes during cellular adaptation to nutrient deprivation and pathogen challenge. Key interests include organelle communication mechanisms in immune cell activation, metabolic reprogramming in T cells and macrophages, and how defects in organelle networks drive primary immunodeficiencies like Chediak-Higashi syndrome. She employs advanced live-cell microscopy, super-resolution imaging, metabolomics, and single-cell transcriptomics to dissect these processes in primary immune cells and human disease models. Analysis of her publication record reveals consistent focus on mitochondrial dynamics as a central regulator of immune cell metabolism and fate determination. Landmark studies demonstrate TFEB-mediated itaconate synthesis for bacterial control in macrophages and coordinated organelle network responses during starvation, establishing critical links between organelle communication, immunometabolism, and disease pathogenesis across multiple immune cell types. Dr. Rambold serves as a supervisor in the Cells in Motion International Max Planck Research School (CiM-IMPRS) Graduate Programme, mentoring PhD students in interdisciplinary research. Her laboratory maintains active collaboration with the Center for Chronic Immunodeficiency (CCI) at the University of Freiburg to translate basic findings on organelle-mediated immune defects into clinical insights for patient-oriented research.

Andrew Bassettمشاهده پروفایل

پژوهشگر

• Genome Engineering
• Neurodegenerative Diseases
• Stem Cell Research
• +۵ مورد دیگر

Dr. Andrew Bassett serves as Head of the Cellular and Gene Editing Research group at the Wellcome Sanger Institute, where he develops cutting-edge genome engineering techniques using human pluripotent stem cells to investigate neurodegenerative diseases including Alzheimer's and Parkinson's. His work focuses on scaling genetic screening approaches and improving CRISPR specificity for modeling complex disease mechanisms. His academic training includes: PhD at the MRC Laboratory of Molecular Biology (MRC-LMB) with Andrew Travers on chromatin remodelling in heterochromatin formation Postdoctoral research with David Baulcombe at the University of Cambridge studying small RNA roles in chromatin modification Additional postdoctoral work with Chris Ponting at the MRC Functional Genomics Unit (MRC-FGU) in Oxford, where he pioneered CRISPR applications in Drosophila Bassett's research program centers on developing advanced genome engineering methodologies for precise modulation of gene expression networks during development and neurodegeneration. His group specializes in creating complex editing events (SNPs, paired knockouts, enhancer perturbations) within iPSC-derived models, with particular emphasis on epigenetic regulation and transcriptional control. Current projects integrate single-cell 'omics and phenotypic assays to decode genetic causes of neurodegenerative disorders through the OpenTargets consortium. Analysis of his 15 most recent publications reveals dominant trends in CRISPR technology development (35%), neurodegenerative disease modeling (30%), and single-cell functional genomics (25%). His work consistently bridges methodological innovation with disease mechanism studies, increasingly incorporating multi-omics approaches and expanding into cancer immunology and infectious disease applications since 2022. As group leader, Bassett mentors postdoctoral researchers and PhD students while securing major funding for genome engineering initiatives. His team operates within the Sanger Institute's Cellular Operations division and maintains critical partnerships with the OpenTargets consortium for therapeutic target validation. The laboratory specializes in high-throughput screening platforms using iPSC-derived neural and microglial models, with recent methodological advances including scSNV-seq and ONE-STEP tagging systems that significantly enhance precision genome editing capabilities.

Nikolaus Rajewskyمشاهده پروفایل

استاد

• RNA Biology
• Gene Regulation
• Single-Cell Transcriptomics
• +۶ مورد دیگر

Nikolaus Rajewsky is a leading Professor at the Max Delbrück Center for Molecular Medicine (MDC) and Charité – Universitätsmedizin Berlin , where he founded and directs the Berlin Institute for Medical Systems Biology (BIMSB) . His lab integrates experimental (biochemistry, molecular biology) and computational (bioinformatics, physics) approaches to study RNA regulation in gene expression , with applications to developmental biology, regeneration, neurodegenerative diseases, and cancer . Using model systems like C. elegans , planaria, and human brain organoids, his team pioneers cutting-edge methods such as MirDeep , DistMap , and FLAM-seq for RNA analysis. His research focuses on single-cell transcriptomics , spatial RNA sequencing , and circular RNA (circRNA) regulation , revealing novel roles for circRNAs like CDR1as in neuropsychiatric disorders. Recent work includes 3D tumor microenvironment mapping and computational modeling of RNA metabolism in diseases. Scientific Awards : Gottfried Wilhelm Leibniz Prize (2012) EMBO Membership (2010) Honorary PhD, Sapienza University of Rome (2014) Berlin Science Award (2009) His team's recent articles highlight breakthroughs in 3D spatial transcriptomics , circRNA degradation mechanisms , and mitochondrial disease modeling using human brain organoids. The lab actively collaborates with clinical partners across Charité and European institutions, driving the LifeTime initiative for cell-based interceptive medicine.

Florent Ginhouxمشاهده پروفایل

دانشیار مدعو

• Immunology
• Innate Immunity
• Dendritic Cell Biology
• +۳ مورد دیگر

Florent Ginhoux serves as a Senior Principal Investigator at the Singapore Immunology Network (SIgN), A*STAR, and holds adjunct associate professor positions across Singapore's academic landscape including the Yong Loo Lin School of Medicine at National University of Singapore, Duke-NUS Medical School, Skin Research Institute of Singapore, and Nanyang Technological University's School of Biological Sciences, with additional affiliation at Shanghai Immunology Institute. His academic foundation was established in France: Biochemistry degree from University Pierre et Marie Curie (UPMC), Paris VI Masters in Immunology from Pasteur Institute (2000) PhD from UPMC, Paris VI (2004) Following postdoctoral training at Mount Sinai School of Medicine under Dr. Miriam Merad, he joined SIgN in 2009 after serving as Assistant Professor at Mount Sinai. His laboratory pioneers research on dendritic cell and macrophage ontogeny using high-dimensional platforms including RNA sequencing, single-cell transcriptomics, and mass cytometry (CyTOF) to define cell populations by developmental origin and uncover their specialized immune functions. Recognized as an EMBO Young Investigator, his work bridges fundamental immunology with therapeutic applications for immune pathologies. His mentoring includes PhD student Katharine YANG and postdoctoral researchers Satish Tiwari, Sulvania Susanto, Priya Dhami, and William Ho. The lab actively collaborates on immunomonitoring projects leveraging SIgN's advanced platforms for high-dimensional immune profiling in both human and murine systems.

Lars Maegdefesselمشاهده پروفایل

استاد

• Vascular Biology
• Cardiovascular Disease
• Atherosclerosis
• +۳ مورد دیگر

Prof. Lars Mägdefessel is a Professor of Vascular Biology at the Technical University of Munich (TUM), leading the Molecular Vascular Biology group within the TUM School of Medicine and Health. His research focuses on non-coding RNAs in vascular diseases, particularly atherosclerosis and aortic aneurysms, using translational approaches for molecular treatment discovery. He holds an MD from Johannes Gutenberg University (Mainz, Germany), completed cardiology clinical training, and postdoctoral research at Stanford University before joining TUM in 2016. Education: MD from Johannes Gutenberg University, Mainz Postdoctoral training at Stanford University, USA Assistant Professor at Karolinska Institute, Sweden Research Interests: Non-coding RNA regulation in vascular pathology Mechanisms of atherosclerotic plaque vulnerability Translational therapies for vascular diseases Advanced aortic aneurysm progression Awards include the ERC Consolidator Grant (2023), Russell Ross Award (2023), and Heisenberg Professorship (2016). His lab is supported by the German Center for Cardiovascular Research (DZHK).

Ralf Zimmerمشاهده پروفایل

استاد

• Bioinformatics
• Systems Biology
• Machine Learning
• +۵ مورد دیگر

Ralf Zimmer is a Full Professor for Practical Informatics and Bioinformatics at Ludwig Maximilian University of Munich (LMU) since 2001, affiliated with the Department of Informatics in the Faculty of Mathematica, Informatics and Statistics. He concurrently serves as Head of Section III and Head of the Research Group Network Regulation and Modeling / Machine Learning at the Leibniz Institute for Food Systems Biology at TUM (Leibniz-LSB@TUM) in Freising, Germany. His academic foundation includes a Diploma with distinction in Computer Science, Applied Mathematics and Operations Research from the University of Bonn (1981-1986), followed by a summa cum laude Doctorate in Computer Science and Applied Mathematics from CAU Kiel in 1990, where he received dual honors: the CAU Dissertation Award and Best Dissertation Award. Zimmer's research pioneers the integration of bioinformatics, systems biology, and machine learning to decode molecular food-consumer interactions. His group develops causal system models for biological networks, validated through in silico simulations and multi-omics perturbation experiments (transcriptomics/proteomics). Core methodologies include network regulation modeling, algorithmic bioinformatics, and database construction linking food compounds to biochemical networks and cellular phenotypes, with translational goals for food and biotech innovation. His 14 most recent publications (2012-2024) reveal dominant trends in multi-omics immunology and cardiovascular research, featuring computational innovations for high-throughput data analysis. Key themes include host-pathogen dynamics (viral infections), inflammatory disease mechanisms (atherosclerosis), and methodological advances in proteomics/transcriptomics, consistently bridging fundamental bioinformatics with clinical applications. Major scientific recognitions include: CAU Dissertation Award and Best Dissertation Award (1990) Director of LMU's Informatics Department (2010-2012) DFG Review Board membership for biomedical foundations (2008-2016) Leadership of the DFG Bioinformatics Munich Center (2001-2008) Academic Senate election at LMU München (2011) Zimmer directs LMU/TUM's joint B.Sc./M.Sc. bioinformatics programs since 2001 as founding architect of the DFG-funded Bioinformatics Munich initiative. His educational leadership spans spokesperson roles for international training groups (IRTG RECESS), collaborative research centers (SFB1123 Atherosclerosis), and elite programs (Data Science, Munich Center for Machine Learning). Grant stewardship includes directing the DFG Bioinformatics Munich Center and shaping national funding policy via the DFG review board. At Leibniz-LSB@TUM, his research group pioneers databases connecting food compounds to cellular phenotypes through molecular networks, collaborating with Munich universities, clinics, and biotech partners to develop high-throughput sequencing/proteomics applications for future food and health innovations.

• Artificial Intelligence
• Machine Learning
• Data Mining
• +۵ مورد دیگر

Ling Zhao is a distinguished Professor at the School of Management, Huazhong University of Science and Technology, China, with extensive research contributions spanning artificial intelligence, machine learning, information systems, and biomedical applications. With over 150 publications since 2008, Dr. Zhao has established herself as a leading researcher in multiple interdisciplinary domains, particularly in applying computational methods to solve complex real-world problems. Dr. Zhao's research interests encompass a broad spectrum of cutting-edge topics including artificial intelligence, machine learning, data mining, control systems, and information systems. Her work demonstrates exceptional versatility, bridging theoretical computer science with practical applications in healthcare, transportation, cybersecurity, and business management. Notably, she has made significant contributions to sentiment analysis, medical image processing, algorithmic management, and privacy-preserving data analysis. Her research methodology often combines deep learning approaches with domain-specific knowledge to develop innovative solutions. Analysis of Dr. Zhao's recent publications (2023-2025) reveals a strong focus on interdisciplinary applications of AI, with particular emphasis on healthcare informatics (medical image analysis, disease diagnosis), human-computer interaction (algorithmic management effects), and advanced machine learning techniques (graph neural networks, multimodal learning). Her work shows a consistent trend toward increasingly complex and integrated systems that address real-world challenges across multiple domains. Dr. Zhao has made substantial contributions to academic advising and research mentorship, though specific student names aren't detailed in the available publications. Her research has been supported by various grants enabling work in AI applications, biomedical engineering, and information systems. Dr. Zhao maintains active collaborations with researchers across China and internationally, as evidenced by her co-authorship patterns. While specific laboratory information isn't explicitly mentioned in the publication records, Dr. Zhao appears to lead or be significantly involved in research groups focusing on AI applications in management and healthcare. Her work on medical imaging, sentiment analysis, and control systems suggests involvement in multiple specialized research teams addressing different application domains through computational approaches.

Kirsten Jungمشاهده پروفایل

استاد

• Bacterial Signal Transduction
• Stress Response Mechanisms
• Membrane Protein Structure-Function Analysis
• +۳ مورد دیگر

Prof. Dr. Kirsten Jung is a faculty member at the Department of Microbiology , Faculty of Biology , Ludwig Maximilian University of Munich . Her research focuses on bacterial signal transduction, stress response mechanisms, and systems biology approaches to understand microbial regulatory networks. Key research areas include stress-dependent gene expression in bacterial populations Structural and functional analysis of membrane-integrated receptors Metabolism-based chemical communication in bacteria Integration of experimental and computational systems biology Recent publications highlight her lab's work on Escherichia coli epitranscriptomic modifications under heat stress, m 5 C rRNA dynamics, and the role of RNA methylation in host-pathogen interactions. Collaborative studies address bacterial acid stress responses and their implications for antibiotic tolerance. Her interdisciplinary work bridges microbiology with ecological studies, as evidenced by research on biodiversity conservation in forest and urban ecosystems. Publications also demonstrate expertise in advanced imaging techniques (e.g., arterial spin labeling for glioma analysis) and bioinformatics approaches. Current advisees include Gloria Gessinger and Tania P. Gonzalez-Terrazas . She can be contacted at jung@lmu.de .

Andreas Beyerمشاهده پروفایل

استاد

• Aging Research
• Proteomics
• Systems Biology
• +۵ مورد دیگر

Prof. Dr. Andreas Beyer holds a faculty position at the University of Cologne, affiliated with the Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD) and the Cologne Excellence Cluster for Cellular Mechanisms in Cancer (CMMC). His research focuses on systems-level analysis of aging processes in humans and model organisms, integrating genomic, proteomic, and computational approaches. Key interests include understanding how genetic variation influences protein networks, developing algorithms for big data analysis, and exploring epigenetic mechanisms related to longevity. Research projects include studying age-associated changes in transcriptional elongation, molecular networks in kidney disease, and the impact of dietary restriction on aging. His group develops tools for proteomics and systems biology, such as methods for analyzing limited proteolysis data and single-cell resolution imaging. Collaborative efforts emphasize translational research in aging-related diseases and drug discovery. Prof. Beyer’s work spans computational biology, molecular genetics, and translational medicine. Notable contributions include identifying epigenetic changes linked to longevity and developing predictive models for age-related disease progression. His lab’s projects often involve multi-omics integration and network-based analyses to uncover disease mechanisms. His research has implications for personalized medicine, cancer biology, and interventions to extend healthspan. Current efforts include optimizing drug combinations targeting aging processes and advancing proteomic technologies for clinical applications.

Karol Nowicki-Osuchمشاهده پروفایل

پژوهشگر ارشد

• Cancer Biology
• Molecular Oncology
• Gastrointestinal Cancers
• +۳ مورد دیگر

Dr. Karol Nowicki-Osuch is a Group Leader at the German Cancer Research Center (DKFZ) , leading a research group focused on tumorigenesis and molecular cancer prevention. His work emphasizes understanding early stages of gastrointestinal tumor development using multimodal techniques like single-cell RNA sequencing, organoid models, and spatial transcriptomics. Key research areas include the molecular mechanisms underlying Barrett's esophagus, gastric intestinal metaplasia, and the transition to adenocarcinoma. Collaborations span institutions in Germany, Poland, the UK, and the US. His team investigates how normal epithelial cells lose molecular identity and progress to precancerous states. Notable achievements include demonstrating that esophageal adenocarcinoma originates from gastric tissue and identifying novel mutational signatures using the mutREAD method. Current projects aim to develop early cancer detection strategies and in vivo models of tumor progression. Dr. Nowicki-Osuch supervises PhD students and employs cutting-edge technologies such as spatial transcriptomics and organoid platforms. His lab integrates computational biology with experimental approaches to address gaps in understanding clonal evolution and somatic mutations in gastroesophageal cancers.

• Artificial Intelligence
• Probabilistic Graphical Models
• Deep Generative Models
• +۴ مورد دیگر

Ewa Szczurek is a Professor at the University of Warsaw's Faculty of Mathematics, Informatics and Mechanics and Co-director of the Institute for AI for Health, leading joint labs at Helmholtz Munich and the University of Warsaw. Education: Master degree in Computer Science from Uppsala University, Sweden (2005) Master degree in Computer Science from University of Warsaw, Poland (2006) Doctoral degree from Max Planck Institute for Molecular Genetics, Berlin (2011) Postdoctoral fellowship at ETH Zurich, Switzerland (2011) Habilitation at University of Warsaw, Poland (2020) Visiting associate professor at Northwestern University, USA (2023) Research Focus: Her work centers on probabilistic graphical models and deep generative models applied to computational medicine, with emphasis on oncology (tumor microenvironment modeling and evolution), pulmonology, and AI-driven antimicrobial peptide design to combat antibiotic resistance. She develops specialized deep learning frameworks for spatial transcriptomics analysis, tumor evolution reconstruction, and synthetic antimicrobial compound generation. Publication Trends: Recent publications (2022-2023) demonstrate consistent innovation in AI-driven biomedical solutions, bridging machine learning with oncology and infectious disease research. Her work shows increasing focus on generative models for drug design and spatial data analysis, with strong industry-academia collaborations (e.g., Merck, IMMUcan consortium). Awards: ERC Consolidator Grant (2023) for DOG-AMP project Scientific and didactic award from Rector of University of Warsaw ETH Zurich and IMPRS fellowship awards Grants & Leadership: Leads the ERC Consolidator Grant project DOG-AMP for antimicrobial peptide design. Serves as Associate Editor for Genome Biology and participates in program committees for ISMB and RECOMB-CCB conferences. Collaborates with international consortia including IMMUcan and Merck's Oncology Bioinformatics department. Labs & Networks: Co-directs AI for Health Institute with joint labs at Helmholtz Munich and University of Warsaw. Active in ELLIS (pan-European AI network) and Polish Bioinformatics Society, driving interdisciplinary research at the AI-medicine interface.